PTHR10373: Difference between revisions

From GO Wiki
Jump to navigation Jump to search
(Created page with "This is a list of questions that arose while PAINTing PTHR_____. =Questions for MOD curators= ==Molecular Function== ===Organism(s) 1=== *'''Question: '''Insert question here. ...")
 
Line 4: Line 4:


==Molecular Function==
==Molecular Function==
===Organism(s) 1===
===Human LEF1===
*'''Question: '''Insert question here.
*'''Question: '''Is the IMP to GO:0043027 "caspase inhibitor activity" in PMID 20360943 appropriate?  Does the experiment really show a biochemical interaction between LEF1 and caspase, or is reduction of caspase activity aresult of mutating LEF1?  If the latter, shouldn't that be a BP annotation?
**'''Curator answer: '''Insert answer here.
**'''Curator answer: '''Insert answer here.


===Organism(s) 2===
===Organism(s) 2===
==Cellular Component==
==Cellular Component==
==Biological Process==
==Biological Process==

Revision as of 15:44, 4 August 2011

This is a list of questions that arose while PAINTing PTHR_____.

Questions for MOD curators

Molecular Function

Human LEF1

  • Question: Is the IMP to GO:0043027 "caspase inhibitor activity" in PMID 20360943 appropriate? Does the experiment really show a biochemical interaction between LEF1 and caspase, or is reduction of caspase activity aresult of mutating LEF1? If the latter, shouldn't that be a BP annotation?
    • Curator answer: Insert answer here.

Organism(s) 2

Cellular Component

Biological Process

Questions for ontology curators

Molecular Function

  • Based on the definition, shouldn't GO:0003705 "sequence-specific enhancer binding RNA polymerase II transcription factor activity" have some sort of relationship, either is_a or has_part, GO:0035326 "enhancer binding"?

Cellular Component

Biological Process